Indian pharma firms operating in China have made some headway into the Chinese market winning bids to supply bulk generic ...

When patients are prescribed complex therapies — like specialty drugs, cell and gene treatments, or high-cost biologics — the path to treatment is rarely straightforward. Filling a prescription can ...

A little over a decade ago, a class of drugs to treat blood cancers arrived on the scene. Known as BTK inhibitors, they block a key enzyme needed by cancer cells to survive. “These drugs turn the ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Rebecca Torrence Every time Rebecca publishes a story, you’ll get an alert straight to your ...

The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In recent years, pharmaceutical companies have broadened their horizons, moving beyond drug ...